Results 231 to 240 of about 2,335,195 (317)

Atherectomy With Multimodal Embolic Protection for Severely Calcified Femoropopliteal Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe calcification in femoropopliteal lesions remains a clinical challenge to achieve both the technical and long‐term success in endovascular therapy. Although atherectomy is an effective treatment for calcified lesions, it is associated with the risk of distal embolization, even with the use of embolic protection devices (EPDs), and ...
Daichi Yoshii, Osamu Iida, Taku Toyoshima, Yoshiteru Okina   +3 more
wiley   +1 more source

2025 Update on resistant hypertension in CKD: where do we stand and where do we go? [PDF]

Clin Kidney J
Schmieder RE.
europepmc   +1 more source

Feasibility and Safety of the ETcath200 Robotic PCI System for Complex Coronary Lesions: A Prospective Single‐Center Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background International robotic‐assisted PCI platforms such as CorPath 200 and CorPath GRX have demonstrated procedural safety and efficacy but are limited by the absence of real‐time tactile feedback and cumbersome device exchange. The ETcath200, the first domestically developed robotic PCI system in China, introduces guidewire force‐sensing
Jing Yang, Yuqi Fang, Yizhu Yan, Zijing Liu, Jing Xie, Ge Zhang, Zhicheng Zhang, Tienan Sun, Guangyao Zhai   +8 more
wiley   +1 more source

Effect of targeted multilevel sleep surgery on resistant hypertension in patients with severe obstructive sleep apnea. [PDF]

J Int Med Res
Bahgat A, Elwany M, Vicini C, Bahgat Y, Magliulo G, Greco A, Virgilio A, Pace A, Bellizzi MG, Croce E, Gatti L, Maniaci A, Lechien JR, Caranti A, Gargula S, Vaira LA, Dos Santos H, Iannella G.   +17 more
europepmc   +1 more source

Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT The liver is increasingly recognized as a major regulator of systemic cardio‐renal‐metabolic health. Evidence is mounting that sex‐chromosome dosage per se itself, independent of gonadal sex hormones, modulates hepatic physiology and liver disease risk.
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen   +2 more
wiley   +1 more source

Increased plasma levels of erythropoietin after renal denervation in patients with resistant hypertension. [PDF]

Hypertens Res
Xu J, Sesa-Ashton G, Eikelis N, Walton A, Lambert EA, Esler MD, Kiuchi MG, Carnagarin R, Lambert GW, Schlaich MP.   +9 more
europepmc   +1 more source

Response to letter by Yao (Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats) [PDF]

, 2010
Dominiczak, A.F., Gallagher, L., Graham, D., Gsell, W., Macrae, I.M., McCabe, C.   +5 more
core   +1 more source

Retrospective, Multicenter Study of Lacosamide to Treat Neonatal Seizures

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Objective Most antiseizure medications (ASMs) are prescribed off label for neonates. Lacosamide's efficacy in infants and availability in intravenous formulation suggest potential utility for neonates. We evaluated the safety and efficacy of lacosamide for neonatal seizures. Methods This 10‐center, retrospective study of neonates with seizures
Alexandra Santana Almansa, Jessica R. Landers, Nicholas S. Abend, Giulia M. Benedetti, Catherine J. Chu, Andrew T. Knox, Shavonne Massey, Steffany Moen, Andrea C. Pardo, Arnold Sansevere, Renée A. Shellhaas, Cameron Thomas, Tammy Tsuchida, Sonya Wang, Bo Zhang, Janet S. Soul   +15 more
wiley   +1 more source

<i>NOS3</i> rs3918188C>A is associated with susceptibility to resistant hypertension while <i>CES1</i> genetic variation was not associated with resistant hypertension among South Africans. [PDF]

Front Genet
Katsukunya JN, Naicker R, Soko ND, Blom D, Sinxadi P, Chimusa ER, Rayner B, Jones E, Dandara C.   +8 more
europepmc   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source